These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2958212)

  • 1. Topical minoxidil sensitization in androgenic alopecia.
    van der Willigen AH; Dutrée-Meulenberg RO; Stolz E; Geursen-Reitsma AM; van Joost T
    Contact Dermatitis; 1987 Jul; 17(1):44-5. PubMed ID: 2958212
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic contact dermatitis to minoxidil.
    Degreef H; Hendrickx I; Dooms-Goossens A
    Contact Dermatitis; 1985 Sep; 13(3):194-5. PubMed ID: 2932293
    [No Abstract]   [Full Text] [Related]  

  • 3. Allergic contact dermatitis from minoxidil.
    Valsecchi R; Cainelli T
    Contact Dermatitis; 1987 Jul; 17(1):58-9. PubMed ID: 2958222
    [No Abstract]   [Full Text] [Related]  

  • 4. Erosive pustular dermatosis of the scalp from topical minoxidil 5% solution.
    Guarneri C; Cannavò SP
    Int J Dermatol; 2013 Apr; 52(4):507-9. PubMed ID: 22040279
    [No Abstract]   [Full Text] [Related]  

  • 5. Pustular dermatosis of the scalp due to topical minoxidil 5.
    El Anzi O; Hassam B
    Pan Afr Med J; 2018; 30():83. PubMed ID: 30344867
    [No Abstract]   [Full Text] [Related]  

  • 6. Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution.
    Hagemann T; Schlütter-Böhmer B; Allam JP; Bieber T; Novak N
    Contact Dermatitis; 2005 Jul; 53(1):53-5. PubMed ID: 15982234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative formulation for patients with contact reactions to topical 2% and 5% minoxidil vehicle ingredients.
    Scheman AJ; West DP; Hordinksy MK; Osburn AH; West LE
    Contact Dermatitis; 2000 Apr; 42(4):241. PubMed ID: 10750861
    [No Abstract]   [Full Text] [Related]  

  • 8. Allergic contact dermatitis from minoxidil.
    Ebner H; Müller E
    Contact Dermatitis; 1995 May; 32(5):316-7. PubMed ID: 7634798
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
    J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scalp comedones after topical minoxidil.
    Baral J
    J Am Acad Dermatol; 1985 Dec; 13(6):1051-2. PubMed ID: 2934443
    [No Abstract]   [Full Text] [Related]  

  • 11. Unusual acute, nonallergic eruptions of the scalp from combined use of minoxidil and retinoic acid.
    Fisher AA
    Cutis; 1993 Jan; 51(1):17-8. PubMed ID: 8419103
    [No Abstract]   [Full Text] [Related]  

  • 12. Allergic contact dermatitis to topical minoxidil solution: etiology and treatment.
    Friedman ES; Friedman PM; Cohen DE; Washenik K
    J Am Acad Dermatol; 2002 Feb; 46(2):309-12. PubMed ID: 11807448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization to saw palmetto and minoxidil in separate topical extemporaneous treatments for androgenetic alopecia.
    Sinclair RD; Mallari RS; Tate B
    Australas J Dermatol; 2002 Nov; 43(4):311-2. PubMed ID: 12423443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contact dermatitis in reaction to 2% topical minoxidil solution.
    Wilson C; Walkden V; Powell S; Shaw S; Wilkinson J; Dawber R
    J Am Acad Dermatol; 1991 Apr; 24(4):661-2. PubMed ID: 1827801
    [No Abstract]   [Full Text] [Related]  

  • 15. Topical minoxidil therapy in hereditary androgenetic alopecia.
    De Villez RL
    Arch Dermatol; 1985 Feb; 121(2):197-202. PubMed ID: 3883902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contact dermatitis to minoxidil.
    Tosti A; Bardazzi F; De Padova MP; Caponeri GM; Melino M; Veronesi S
    Contact Dermatitis; 1985 Oct; 13(4):275-6. PubMed ID: 4085233
    [No Abstract]   [Full Text] [Related]  

  • 17. Contact dermatitis due to topical spironolactone.
    Fernandez-Vozmediano JM; Gil-Tocados G; Manrique-Plaza A; Romero-Cabrera MA; Picazo-Sanchez J; Nieto-Montesinos I
    Contact Dermatitis; 1994 Feb; 30(2):118-9. PubMed ID: 8187494
    [No Abstract]   [Full Text] [Related]  

  • 18. Erosive pustular dermatosis of the scalp following topical latanoprost for androgenetic alopecia.
    Vaccaro M; Barbuzza O; Borgia F; Cannavò SP
    Dermatol Ther; 2015; 28(2):65-7. PubMed ID: 25627907
    [No Abstract]   [Full Text] [Related]  

  • 19. Androgenetic alopecia treated with topical minoxidil.
    De Villez RL
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):669-72. PubMed ID: 3549800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical minoxidil for hair regrowth.
    Vanderveen EE; Ellis CN; Kang S; Case P; Headington JT; Voorhees JJ; Swanson NA
    J Am Acad Dermatol; 1984 Sep; 11(3):416-21. PubMed ID: 6384289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.